Literature DB >> 1247259

Increased risk for spondylitis stigmata in apparently healthy HL-AW27 men.

L M Cohen, K K Mittal, F R Schmid, L F Rogers, K L Cohen.   

Abstract

Evidence for ankylosing spondylitis was sought by clinical, radiologic, and ophthalmologic examination in HL-A W27-positive men, aged 18 or older, selected from a tissue-donor population. Back pain of 3 months' duration or longer (P less than 0.05), back stiffness, restricted lumbar flexion and chest expansion, sacroiliac erosions (P less than 0.05) and sclerosis, and ophthalmologic sequels of anterior uveitis were found more often in the 24 men of the W27 group than in a control group of 31 men lacking this antigen. Based upon accepted criteria, 3 W27 persons had definite spondylitis and an additional 3 W27 persons and one control subject had findings strongly suggestive of spondylitis (P less than 0.05). This striking frequency, if extrapolated to the general population, would place approximately 1 of 4 W27-positive men at risk for this disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247259     DOI: 10.7326/0003-4819-84-1-1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway.

Authors:  J T Gran; G Husby; M Hordvik
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

2.  The role of HLA antigens in disease.

Authors:  K K Mittal
Journal:  Indian J Pediatr       Date:  1980 Sep-Oct       Impact factor: 1.967

3.  HLA B27 and the genetics of ankylosing spondylitis.

Authors:  J C Woodrow; C J Eastmond
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

4.  The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration.

Authors:  W J Meyler; H Bakker; J J Kok; S Agoston; H Wesseling
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

5.  Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.

Authors:  B J Dekker-Saeys; S G Meuwissen; E M Van Den Berg-Loonen; W H De Haas; K A Meijers; G N Tytgat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

6.  The relationship between genetics and environment in the pathogenesis of rheumatic diseases.

Authors:  A Calin
Journal:  West J Med       Date:  1979-09

7.  HLA-B27 in possible ankylosing spondylitis with peripheral arthritis.

Authors:  H Zeidler; P Wagener; G Eckert; J Freyschmidt; R Fritsch; H Creutzig; H Deicher
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

8.  Clinical study of Thai patients with ankylosing spondylitis.

Authors:  U Deesomchok; T Tumrasvin
Journal:  Clin Rheumatol       Date:  1985-03       Impact factor: 2.980

9.  Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals.

Authors:  R W Karr; Y Hahn; B D Schwartz
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

Review 10.  The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.

Authors:  John D Reveille; Michael H Weisman
Journal:  Am J Med Sci       Date:  2013-06       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.